المؤلفون: Arevalo J.F., Sanchez J.G., Lasave A.F., Wu L., Maia M., Bonafonte S., Brito M., Alezzandrini A.A., Restrepo N., Berrocal M.H., Saravia M., Farah M.E., Fromow-Guerra J., Morales-Canton V., Espinoza J.V., Aggio F.B., Quiroz-Mercado H., Guerrero-Naranjo J.L., Rodriguez F.J., Infante R., Medina D., Cruz-Villegas V., Graue-Wiechers F., Lozano-Rechy D., Robledo V., Rodriguez-Loaiza J.L., Roca J.A., Reategui G., Saravia M.J., Martinez-Cartier M., Avila M., Cardillo J., Costa R.A., Verdaguer J., Carpentier C., Verdaguer J.I., Filsecker D.L., Sepúlveda G., Sanchez F., Marini C., Garcia B., Pan-American Collaborative Retina Study Group (PACORES)

المصدر: instname:Universidad del Rosario

مصطلحات موضوعية: Bevacizumab, Angiogenesis inhibitor, Monoclonal antibody, Article, Diabetic macular edema, Diabetic retinopathy, Disease severity, Follow up, Human, Laser coagulation, Macular thickness, Priority journal, Proliferative diabetic retinopathy, Retina detachment, Treatment outcome, Visual acuity, Adult, Aged, Animal, Cell proliferation, Drug effect, Evaluation, Female, Intravitreal drug administration, Male, Middle aged, Optical coherence tomography, Retina macula edema, Retrospective study, Time

وصف الملف: application/pdf

Relation: https://repository.urosario.edu.co/handle/10336/23801; https://doi.org/10.2174/157339910793360842

الاتاحة: https://repository.urosario.edu.co/handle/10336/23801
https://doi.org/10.2174/157339910793360842

المؤلفون: Alezzandrini, A.A.

المصدر: Ophthalmologica; 1964, Vol. 147 Issue 5, p409-419, 11p